Publication:
FOLFOX4 in metastatic colorectal cancer (MCRC) patients who progressed after infusional 5-FU/irinotecan based combination regimens.

Simple item page
dc.contributor.authorsDane, F; Yumuk, PF; Turhal, NS; Ekenel, M; Basaran, G; Iyikesici, MS; Tecimer, C
dc.date.accessioned2022-03-12T15:58:52Z
dc.date.accessioned2026-01-10T17:24:16Z
dc.date.available2022-03-12T15:58:52Z
dc.date.issued2004
dc.identifier.doidoiWOS:000223512401193
dc.identifier.issn0732-183X
dc.identifier.urihttps://hdl.handle.net/11424/224199
dc.identifier.wosWOS:000223512401193
dc.language.isoeng
dc.publisherAMER SOC CLINICAL ONCOLOGY
dc.relation.ispartofJOURNAL OF CLINICAL ONCOLOGY
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.titleFOLFOX4 in metastatic colorectal cancer (MCRC) patients who progressed after infusional 5-FU/irinotecan based combination regimens.
dc.typeconferenceObject
dspace.entity.typePublication
oaire.citation.endPage301S
oaire.citation.issue14
oaire.citation.startPage301S
oaire.citation.titleJOURNAL OF CLINICAL ONCOLOGY
oaire.citation.volume22

Files

Collections

Araştırma Çıktıları